The Institute will foster multidisciplinary research across fields such as health, agriculture, arts, social sciences, business, and Net Zero initiatives. Australian researchers will collaborate closely with Vietnamese counterparts on vital projects, including advancing public health efforts, combating tuberculosis, developing technologies for breast cancer diagnosis, and exploring Vietnam’s potential as a media innovation hub. In an exclusive interview, Institute Director Professor Thu-Anh Nguyen, a renowned infectious diseases and public health researcher, shares insights into how the Vietnam Institute will elevate the country’s research landscape and drive impactful collaborations. Edited excerpts:
What was the rationale behind choosing Vietnam as the location for this institute, and how does the country’s academic and research landscape complement the University of Sydney’s goals?
Vietnam was chosen as the location for the Sydney Vietnam Institute (SVI) because of the strong, long-standing relationship between the University of Sydney and Vietnam. Since the 1990s, over 240 University of Sydney academics have visited Vietnam to work on important shared issues like climate change, health, food security, agricultural technology transformation, ageing populations, urban development and regional economic growth. This history of collaboration made Vietnam an ideal place to deepen academic ties. The SVI’s multidisciplinary research focuses on improving the well-being of communities in Vietnam and beyond through multidisciplinary collaboration. By fostering partnerships between Australian and Vietnamese researchers, the Institute promotes sustainable and mutually beneficial cooperation across all levels of higher education and research engagement.
この記事は BioSpectrum Asia の BioSpectrum Asia Nov 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は BioSpectrum Asia の BioSpectrum Asia Nov 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.
Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.
Eppendorf brings CO2 incubator shaker with integrated 180 °C sterilisation routine
Eppendorf has announced the launch of a CO2 incubator shaker with integrated 180 °C sterilisation routine.
Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis
US-based Waters Corporation has introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence and modification confirmation of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LCMS) analysis.
Singapore designs novel gene therapy offering hope for epilepsy patients
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore are working on a therapy that holds potential in treating patients with epilepsy, a neurological disorder defined by recurring seizures due to abnormal brain activity.
Spider venom heart drug moves to clinical trials in Australia
A University of Queensland (UQ)-led project in Australia to develop the first-ever drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF).
India develops portable ultrasound scanner for sports injury diagnosis
A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-CareUltrasound (POCUS) Scanner for sports injury diagnosis and management.
Integris appoints medtech veteran Probir Das as new CEO
Integris Healthcare, a global diversified medical technology company, has announced the appointment of Probir Das as Chief Executive Officer (CEO). He will join effective November 2024 and will be based in New Delhi.
Clarity Pharma promotes Michelle Parker to CEO
Australia-based Clarity Pharmaceuticals has announced the appointment of Michelle Parker as Chief Executive Officer (CEO), effective from October 11, 2024.
Dr Makoto Sugita steps in as President of Nxera Pharma Japan
Nxera Pharma Co., formerly known as Sosei Group or Sosei Heptares, has announced the appointment of Dr Makoto Sugita, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (CMO) of Nxera Pharma.